What Happened?
Cardiff by the Sea, CA-based Viracta-Therapeutics Appointed Ivor Royston as President and Chief Executive Officer
About the Company
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
About the Person
Ivor Royston is President and Chief Executive Officer at Viracta Therapeutics. Previously, Ivor held various senior HR leadership roles in the industry.
Info Source
News
Short Profile